Aspirin’s Chemopreventive Effects Indicated In Hodgkin’s Lymphoma Study
This article was originally published in The Tan Sheet
Use of aspirin roughly two times per week over five years may lower the risk for Hodgkin's lymphoma, researchers report in a study exploring an inverse association between the cancer and use of aspirin, other NSAIDS and acetaminophen
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC